CWBHF Charlotte's Web Holdings, Inc.
Price Chart
Executive Summary
Co-founder Jared Stanley resigned from the Board of Directors effective June 3, 2026, to focus full-time on his role as CEO of DeFloria, a clinical-stage affiliate developing a Phase 2 botanical drug for autism-related irritability. The departure is amicable and supported by management, with Stanley remaining in an advisory capacity and Charlotte's Web retaining its shareholder stake in DeFloria. This is a routine board transition with no financial impact or disagreement disclosed.
Actionable Insight
Monitor for any future 8-K filings regarding DeFloria's Phase 2 trial progress or financing, as Charlotte's Web's equity stake in DeFloria represents a potential catalyst. No immediate trading action warranted based on this board transition alone.
Key Facts
- Co-founder Jared Stanley resigned from the Board of Directors effective June 3, 2026.
- Stanley will continue as CEO of DeFloria, a clinical-stage affiliate developing AJA001 for autism-related irritability.
- Stanley will remain in an advisory capacity to Charlotte's Web.
- The resignation is not related to any disagreement with the company, management, or board.
- Board size reduces to six directors following the departure.
- Charlotte's Web remains a co-founder and shareholder in DeFloria.
Financial Impact
No financial figures disclosed; no material impact expected.
Risk Factors
- Loss of co-founder board presence could reduce strategic oversight of cultivation and regulatory initiatives.
- DeFloria's clinical-stage pipeline carries inherent development and regulatory risk.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001750155-26-000097 |
| Document: cweb_jun5x2026jaredstanley.htm | 0001750155-26-000097 |
| Document: 0001750155-26-000097-index-headers.html | 0001750155-26-000097 |
| Document: 0001750155-26-000097-index.html | 0001750155-26-000097 |
| Document: 0001750155-26-000097.txt | 0001750155-26-000097 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
9d ago
|
8-K
| $0.4390 awaiting T+1 | awaiting T+1 | — | $0.3980 (−9.34%) |
|
Jun 3, 2026
11d ago
|
8-K
| $0.4170 $0.4320 | ▲ +3.60% | ▲ +6.20% | $0.3980 (−4.56%) |
|
Jun 1, 2026
13d ago
|
8-K
| $0.4910 $0.4260 | ▼ −13.24% | ▼ −12.52% | $0.3980 (−18.94%) |
|
May 13, 2026
4w ago
|
8-K
| $0.4860 $0.4520 | ▲ +7.00% | ▲ +7.77% | $0.3980 (+18.11%) |
|
Apr 16, 2026
8w ago
|
DEFA14A
| $0.6080 $0.6150 | ▲ +1.15% | ▼ −0.06% | $0.3980 (−34.54%) |
|
Mar 31, 2026
10w ago
|
8-K
| $0.7350 $0.7820 | ▲ +6.39% | ▲ +5.65% | $0.3980 (−45.85%) |
|
Mar 31, 2026
10w ago
|
DEFA14A
| $0.7350 $0.7820 | ▲ +6.39% | ▲ +5.65% | $0.3980 (−45.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access